Literature DB >> 20637236

Sex hormones and autoimmunity.

Delia Almeida González1, Buenaventura Brito Díaz, María del Cristo Rodríguez Pérez, Ana González Hernández, B Nicolás Díaz Chico, Antonio Cabrera de León.   

Abstract

Autoimmune diseases occur more in women than in men, and this may be attributable to the role of estrogens. Androgens promote autoimmune diseases with a profile of type 1 cytokines, such as rheumatoid arthritis, whereas estrogens promote autoimmune diseases with a type 2 cytokine profile, like systemic lupus erythematosus. Both androgens and estrogens regulate the Th1/Th2 balance. Type 1 autoimmune diseases are improved when decrease type 1 cytokines (i.e. during fasting), or when there is a rise in type 2 cytokines (increased estrogens, as in pregnancy). Type 2 autoimmune diseases improve when type 2 cytokines are diminished (decreased estrogen, as in post-partum period) or when type 1 response is stimulated. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20637236     DOI: 10.1016/j.imlet.2010.07.001

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  38 in total

Review 1.  Ovarian stimulation and embryo banking for fertility preservation in a woman with severe mixed connective tissue disease: Is it safe?

Authors:  Vasileios D Sioulas; Clarisa R Gracia
Journal:  J Assist Reprod Genet       Date:  2011-12-29       Impact factor: 3.412

2.  Acute immunomodulatory changes during controlled ovarian stimulation: evidence from the first trial investigating the short-term effects of estradiol on biomarkers and B cells involved in autoimmunity.

Authors:  Anna Ghirardello; Salvatore Gizzo; Marco Noventa; Michela Quaranta; Amerigo Vitagliano; Nicoletta Gallo; Giorgia Pantano; Marianna Beggio; Chiara Cosma; Michele Gangemi; Mario Plebani; Andrea Doria
Journal:  J Assist Reprod Genet       Date:  2015-10-14       Impact factor: 3.412

3.  Clinical features and outcomes of 98 children and adults with dense deposit disease.

Authors:  Der-Fa Lu; Mikyung Moon; Lynne D Lanning; Ann Marie McCarthy; Richard J H Smith
Journal:  Pediatr Nephrol       Date:  2011-11-22       Impact factor: 3.714

Review 4.  Progesterone and autoimmune disease.

Authors:  Grant C Hughes
Journal:  Autoimmun Rev       Date:  2011-12-13       Impact factor: 9.754

Review 5.  Gender difference in gastro-esophageal reflux diseases.

Authors:  Kiyotaka Asanuma; Katsunori Iijima; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2016-02-07       Impact factor: 5.742

Review 6.  Emerging roles for the interferon-inducible p200-family proteins in sex bias in systemic lupus erythematosus.

Authors:  Divaker Choubey; Ravichandran Panchanathan; Xin Duan; Hongqi Liu; Hongzhu Liu
Journal:  J Interferon Cytokine Res       Date:  2011-09-08       Impact factor: 2.607

7.  Hormone therapy increases risk of ulcerative colitis but not Crohn's disease.

Authors:  Hamed Khalili; Leslie M Higuchi; Ashwin N Ananthakrishnan; JoAnn E Manson; Diane Feskanich; James M Richter; Charles S Fuchs; Andrew T Chan
Journal:  Gastroenterology       Date:  2012-07-27       Impact factor: 22.682

Review 8.  Risk of Inflammatory Bowel Disease with Oral Contraceptives and Menopausal Hormone Therapy: Current Evidence and Future Directions.

Authors:  Hamed Khalili
Journal:  Drug Saf       Date:  2016-03       Impact factor: 5.606

9.  Estrogen-mediated downregulation of AIRE influences sexual dimorphism in autoimmune diseases.

Authors:  Nadine Dragin; Jacky Bismuth; Géraldine Cizeron-Clairac; Maria Grazia Biferi; Claire Berthault; Alain Serraf; Rémi Nottin; David Klatzmann; Ana Cumano; Martine Barkats; Rozen Le Panse; Sonia Berrih-Aknin
Journal:  J Clin Invest       Date:  2016-03-21       Impact factor: 14.808

10.  Is there an association between alopecia areata and systemic lupus erythematosus? A population-based study.

Authors:  Khalaf Kridin; Guy Shalom; Doron Comaneshter; Arnon D Cohen
Journal:  Immunol Res       Date:  2020-02       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.